Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers

Bile duct, pancreatic, and gastric cancers are deadly digestive system tumors with high malignancy and poor patient prognosis. The efficiencies of conventional surgical treatment, radiation therapy, and chemotherapy are limited. In contrast, chimeric antigen receptor (CAR) T-cell therapy represents...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qiang, Sun, Baozhen, Xue, Tianyi, Li, Rong, Lin, Chao, Gao, Yongjian, Sun, Liqun, Zhuo, Yue, Wang, Dongxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628995/
https://www.ncbi.nlm.nih.gov/pubmed/36341440
http://dx.doi.org/10.3389/fimmu.2022.1025608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628995/
https://www.ncbi.nlm.nih.gov/pubmed/36341440
http://dx.doi.org/10.3389/fimmu.2022.1025608

Ejemplares similares